And the molecular modifications that separate them, tiny changes at the amino acid level, create a gap in potency, convenience, and clinical results that surprises even seasoned researchers
Dual agonists: Tirzepatide, which targets both GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) receptors, enhancing metabolic effects beyond single-target approaches
I had seen a patient who had NAION, and she was on Ozempic
Yes, patients have access to providers who can prescribe over 2,000+ personalized solutions across more than a 100 conditions, including weight loss, mental health, longevity, and more
One video visit every three months is required, additional video visits cost nothing extra, and portal messaging is open between appointments